# Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes

> **NIH NIH R01** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2021 · $481,119

## Abstract

Numerous mechanisms have been proposed as contributing factors in the etiology of diabetic cardiomyopathy,
ranging from neurohumoral imbalances and extracellular remodeling, to perturbations in the intrinsic properties
of cardiomyocytes. In the latter case, imbalances in rates of damage (e.g., oxidative) and replacement (i.e.,
turnover) of cellular constituents (e.g., proteins, mitochondria) have been implicated in the development of
cardiac dysfunction during diabetes. Although many studies have investigated the role of increased oxidative
stress, little is known regarding how diabetes impairs the turnover of damaged cellular constituents.
Turnover of cellular constituents exhibits a striking time-of-day-dependent variation, which is governed by the
cardiomyocyte circadian clock. Moreover, genetic disruption of the clock in the heart temporally suspends
these processes, leading to development of dilated cardiomyopathy. Compelling evidence presented within
this application suggests that both autophagy and mitophagy (autophagy of mitochondria), processes critical in
the repair/replacement of cellular constituents, are circadian regulated in the heart. Our investigation of the
cardiomyocyte circadian clock further revealed that the posttranslational modification, protein O-GlcNAcylation,
is integral to the clock mechanism; the importance of this relationship is highlighted during diabetes (both type
1 and 2), when chronic elevation of cardiac protein O-GlcNAcylation (secondary to aberrant glucose
metabolism) is associated with a phase shift in the clock within the heart. We postulate therefore that
disruption of the clock-O-GlcNAc relationship during diabetes causes temporal misalignment of
cardiac processes involved in repair/replacement of cellular constituents. These studies have led to the
hypothesis that chronic disruption of the clock-O-GlcNAc relationship in the heart during T2DM
impairs temporal partitioning of autophagy/mitophagy, ultimately impairing cellular constituent quality
control leading to contractile function. In order to test this hypothesis, three Specific Aims are proposed.
Aim 1: Demonstrate that the cardiomyocyte circadian clock modulates quality control of cellular
constituents through transcriptional and posttranslational regulation of autophagy/mitophagy
mediators (Physiologic/Mechanistic Aim). Aim 2: Demonstrate that chronic disruption of the clock-O-
GlcNAc relationship during T2DM impairs quality control of cellular constituents through attenuated
temporal partitioning of autophagy/mitophagy (Pathologic Aim). Aim 3: Demonstrate that behavior-
and/or pharmacologic- mediated normalization of the clock-O-GlcNAc relationship during T2DM
attenuates development of cardiac dysfunction (Therapeutic Aim). Successful completion of the
proposed studies will lead to new fundamental insights regarding the causal role of circadian disruption in the
etiology of diabetic cardiomyopathy, and will help identify innovative approaches for...

## Key facts

- **NIH application ID:** 10078980
- **Project number:** 5R01HL142216-04
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** JOHN C CHATHAM
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $481,119
- **Award type:** 5
- **Project period:** 2018-04-15 → 2023-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10078980

## Citation

> US National Institutes of Health, RePORTER application 10078980, Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes (5R01HL142216-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10078980. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
